ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,749.22
0.04%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Chemgenex Pharmaceuticals Ltd (MM) (CXSP)

  7. Chemgenex Pharmaceuticals Ltd (MM) (CXSP) News

Chemgenex (CXSP)

Chemgenex Pharmaceuticals Ltd (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CXSP
DateTimeSourceHeadlineSymbolCompany
29/06/200914:19Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
01/06/200917:00Business WirePivotal Study Results: ChemGenex’s Omacetaxine May Provide the First Viable Drug Treatment Option for Patients With a Highl...NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
22/05/200911:17Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
21/05/200912:00Business WireChemGenex’s Omacetaxine to be Showcased in Three Oral Presentations at EHANASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
18/05/200920:07Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
15/05/200900:30Business WireChemGenex to Present Pivotal Data in T315I Positive CML Patients as Oral Presentation at ASCONASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
04/05/200915:54Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
09/04/200911:00Business WireChemGenex Completes Capital Raising, Announces Rights IssueNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
31/03/200912:09Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
26/03/200910:40Business WireNew Data Suggesting that ChemGenex’s Omacetaxine Can Eradicate Leukemic Stem Cells May Offer a Breakthrough in Treating CMLNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
20/01/200917:10Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
15/01/200915:45Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
30/12/200819:00Edgar (US Regulatory)Annual and Transition Report (foreign private issuer) (20-F)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
09/12/200816:28Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
16/06/200820:04Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd - Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
01/04/200815:59Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd - Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
01/04/200813:00Business WireChemGenex Investigators Present Data on Clinical Activity of Omacetaxine in Imatinib-Resistant Chronic Myeloid Leukemia PatientsNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
29/02/200817:41Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd - Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
07/01/200812:41Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd - Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
03/01/200815:55Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd - Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
27/11/200722:25Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd - Annual and Transition Report (foreign private issuer) (20-F)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
30/10/200716:02Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd - Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
30/10/200716:02Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd - Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
01/10/200715:41Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd (Other) (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
11/06/200721:30Business WireChemGenex Announces Publication Confirming Activity of Ceflatonin(R) in T315I-Positive CMLNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
03/04/200703:27Business WireChemGenex Announces the Completion of A$21 Million FinancingNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
05/01/200717:08Business WireChemGenex Pharmaceuticals: Announcement Pursuant To Nasdaq Marketplace Rule 4350(b)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
04/04/200613:00PR Newswire (US)Preclinical Progress Reported at American Association of Cancer Research ConferenceNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
22/03/200623:26PR Newswire (US)New Preclinical Research Supports Ceflatonin(R) in Treatment of Acute Myeloid Leukemia (AML)NASDAQ:CXSP
20/03/200604:40PR Newswire (US)Orphan Drug Designation Granted by the U.S. FDA for Ceflatonin(R)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
 Showing the most relevant articles for your search:NASDAQ:CXSP

Your Recent History

COIN
SAFEUSD
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved